期刊文献+

Sp1促进A549细胞增殖、EMT、侵袭和血管生成的研究 被引量:2

Sp1 Promotes Proliferation,EMT,Invasion and Angiogenesis in A549 Cells
原文传递
导出
摘要 研究Sp1转录调控原癌基因c-Met促进肺癌A549细胞增殖、EMT转化、侵袭和血管生成,抑制A549细胞凋亡的分子机制.首先采用双荧光素酶报告基因和染色质免疫共沉淀(ChIP)法检测Sp1与c-Met基因启动子结合情况.之后,在A549细胞中过表达和沉默表达Sp1,Western-blotting法和免疫荧光法研究Sp1转录调控c-Met,促进A549细胞增殖、EMT转化、血管生成,侵袭并抑制A549细胞凋亡的分子机制.与癌旁组织和正常组织相比,在肺癌组织样本中,Sp1和c-Met均呈现高表达;Sp1能够与c-Met基因启动子结合;Sp1转录调控c-Met通过激活c-Met-ERK通路,促进A549细胞增殖、抑制A549细胞凋亡;Sp1转录调控c-Met亦能促进A549细胞EMT转化,侵袭和血管生成.Sp1转录调控c-Met能够促进A549细胞增殖、EMT转化,侵袭和血管形成,抑制A549细胞凋亡.在肺癌发生发展进程中,Sp1转录调控c-Met发挥重要作用. This article aims to investigate the molecular mechanism by which Sp1 transcriptionally regulates the proto-oncogene c-Met to promote proliferation,EMT transformation,invasion,migration and angiogenesis of lung cancer A549 cells and inhibit apoptosis of A549 cells.The binding of Sp1 to the c-Met gene promoter was first detected by using a dual luciferase reporter gene and chromatin immunoprecipitation(ChIP)method.Subsequently,Sp1 was overexpressed and silently expressed in A549 cells,and the molecular mechanisms by which Sp1 transcriptionally regulates c-Met to promote A549 cell proliferation,EMT transformation,angiogenesis,invasion,migration,and inhibit A549 cell apoptosis were investigated by Western-blotting and immunofluorescence assays.Both Sp1 and c-Met were highly expressed in lung cancer samples compared to paraneoplastic and normal tissues.Sp1 is able to bind to the c-Met gene promoter.Sp1 transcriptional regulation of c-Met promotes A549 cell proliferation and inhibits A549 cell apoptosis through activation of the c-Met-ERK pathway.Sp1 transcriptional regulation of c-Met also promotes EMT transformation,invasion,migration and angiogenesis in A549 cells.Sp1 transcriptional regulation of c-Met promotes A549 cell proliferation,EMT transformation,invasion,migration and angiogenesis,and inhibits A549 cell apoptosis.Sp1 transcriptional regulation of c-Met plays an important role in the development of lung cancer.
作者 秦书华 彭俊 高创创 桂浩鑫 邵钰婷 郝倩 向诚 徐天瑞 刘莹 QIN Shuhua;PENG Jun;GAO Chuangchuang;GUI Haoxin;SHAO Yuting;HAO Qian;XIANG Cheng;XU Tianrui;LIU Ying(Faculty of Life Science and Technology,Kunming University of Science and Technology,Kunming 650500,China;Thoracic Surgery,Yunnan First People's Hospital,Kunming 650034,China;Institute of Life Sciences,Jinzhou Medical University,Jinzhou,Liaoning 121001,China)
出处 《昆明理工大学学报(自然科学版)》 北大核心 2022年第3期123-130,共8页 Journal of Kunming University of Science and Technology(Natural Science)
基金 国家自然科学基金项目(81560455)。
关键词 Sp1转录因子 细胞增殖 原癌基因C-MET EMT转化 侵袭 血管生成 Sp1 transcription factor cell proliferation proto-oncogene c-Met EMT transformation invasion angiogenesis
  • 相关文献

参考文献5

二级参考文献106

  • 1Toshiyuki Otsuka,Norio Horiguchi,Daisuke Kanda,Takashi Kosone,Yuichi Yamazaki,Kazuhisa Yuasa,Naondo Sohara,Satoru Kakizaki,Ken Sato,Hitoshi Takagi,Glenn Merlino,Masatomo Mori.Overexpression of NK2 inhibits liver regeneration after partial hepatectomy in mice[J].World Journal of Gastroenterology,2005,11(47):7444-7449. 被引量:2
  • 2Varughese S,Jahangir KS,Simpson CE,et al. A paradigm shift in the treatment of advanced non-small cell lung can- cer[J]. Am J Med Sci,2012,344(2) : 147-150.
  • 3Siegfried JM,Gubish CT,Rothstein ME,et al. Combining the multitargeted tyrosine kinase inhibitor vandetanib with the antiestrogen fulvestrant enhances its antitumor effect in non-small cell lung cancer [J]. J Thorac Oncol,2012,7 (3) : 485-495.
  • 4D'Areangelo M,Cappuzzo F. Erlotinib in the first-line treatment of non-small-cell lung cancer [J]. Expert Rev Anticancer Ther,2013,13(5):523-533.
  • 5Pao W, Girard N. New driver mutations in non-small-cell lung cancer[J]. Lancet Oncol, 2011,12(2) : 175-180.
  • 6Nakamura T, Nawa K, Ichihara A. Partial purification and characterization of hepatocyte growth factor from serum of hepatectomized rats [J]. Biochem Biophys Res Commun, 1984, 122(3): 1450-1459.
  • 7Radtke S,Milanovic M,Ross6 C,et al. ERK2 but not ERK1 mediates HGF-induced motility in non-small cell lung carcinoma cell lines [J]. J Cell Sci,2013,126(11): 2381-2391.
  • 8Yano S,Yamada T,Takeuchi S,et al. Hepatocyte growth factor expression in EGFR mutant lung cancer with intrin- sic and acquired resistance to tyrosine kinase inhibitors in a Japanese cohort [J].J Thorac Oncol, 2011,6 (12) : 2011 - 2017.
  • 9Gherardi E,Birchmeier W,Birchmeier C,et al. Targeting MET in cancer:rationale and progress [J]. Nat Rev Can- cer, 2012,12(2) : 89-103.
  • 10Ogunwobi OO,Puszyk W,Dong HJ,et al. Epigenetic Up- regulation of HGF and c-MET Drives Metastasis in Hepa- tocellular Carcinoma[J]. PLoS One,2013,8(5):e63765.

共引文献29

同被引文献9

引证文献2

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部